ABIVAX (EPA:ABVX) | WebDisclosure

BRIEF

published on 05/08/2024 at 08:35, 6 months 15 days ago

Présentation d'Obefazimod pour la rectocolite hémorragique et le cancer du côlon lors de DDW 2024

Abivax Obefazimod Rectocolite Hémorragique Digestive Disease Week Cancer Du Côlon
PRESS RELEASE

published on 05/08/2024 at 08:31, 6 months 15 days ago

Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024
Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024. Des nouvelles données seront partagées concernant le candidat médicament obefazimod

Abivax Obefazimod Rectocolite Hémorragique Digestive Disease Week Cancer Du Côlon
PRESS RELEASE

published on 05/08/2024 at 08:31, 6 months 15 days ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax presents four abstracts on obefazimod for ulcerative colitis and colon cancer model at Digestive Disease Week 2024. The company highlights novel mechanism of action and positive clinical data for obefazimod

Abivax Obefazimod Ulcerative Colitis Digestive Disease Week Colon Cancer
PRESS RELEASE

published on 05/08/2024 at 08:30, 6 months 15 days ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024. The event will showcase new data on obefazimod's impact and mechanism of action

Abivax Obefazimod Ulcerative Colitis Colon Cancer Digestive Disease Week 2024
PRESS RELEASE

published on 05/08/2024 at 08:30, 6 months 15 days ago

Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024
Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024

Abivax Obefazimod Rectocolite Hémorragique Cancer Du Côlon Digestive Disease Week 2024
BRIEF

published on 05/07/2024 at 22:05, 6 months 16 days ago

Abivax annonce la mise à disposition des documents pour la prochaine assemblée générale

Biotechnologie Abivax Assemblée Générale Gouvernance D'Entreprise Informations Pour Les Actionnaires
BRIEF

published on 05/07/2024 at 22:05, 6 months 16 days ago

Abivax Announces Availability of Documents for Upcoming General Meeting

Biotechnology Shareholder Information Corporate Governance Abivax General Meeting
PRESS RELEASE

published on 05/07/2024 at 22:01, 6 months 16 days ago

Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires
Abivax annonce la tenue de son assemblée générale annuelle et extraordinaire le 30 mai 2024 à Paris. Mise à disposition des documents préparatoires pour les actionnaires

Biotechnologie Abivax Obefazimod Assemblée Générale Documents Préparatoires
PRESS RELEASE

published on 05/07/2024 at 22:00, 6 months 16 days ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax informs shareholders of its ordinary and extraordinary general meeting on May 30, 2024, providing access to preparatory documents and details on participation. Obefazimod and Abivax information included

Abivax Obefazimod General Meeting Clinical-stage Biotechnology Preparatory Documents
PRESS RELEASE

published on 05/07/2024 at 22:00, 6 months 16 days ago

Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires
Abivax annonce son assemblée générale annuelle et extraordinaire du 30 mai 2024 avec la mise à disposition des documents préparatoires. L'événement se tiendra à Paris

Biotechnologie Abivax Assemblée Générale Traitements Thérapeutiques Documents Préparatoires

Published on 11/22/2024 at 23:55, 1 day 4 hours ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 5 hours ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 5 hours ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day 5 hours ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 6 hours ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 10 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 10 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 10 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 11 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 12 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 17:45, 1 day 11 hours ago

IMMERSION : RFA 2023/2024
Published on 11/22/2024 at 16:15, 1 day 12 hours ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 1 day 14 hours ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 1 day 14 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 21 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE

News